PLoS ONE, 2015 · DOI: 10.1371/journal.pone.0118550 · Published: March 17, 2015
This study investigates neurogenesis, the generation of new neurons, during autoimmune brain inflammation using a technique called bioluminescence imaging (BLI). The researchers used transgenic mice that express luciferase, a light-emitting enzyme, under the control of a marker for neuronal progenitor cells (NPCs). They found that while BLI initially showed an increase in neurogenesis during experimental autoimmune encephalomyelitis (EAE), further analysis revealed this was likely due to a leaky blood-brain barrier, rather than actual changes in neurogenesis.
When using BLI to study neurogenesis or other CNS processes during inflammation, researchers need to be cautious about interpreting changes in bioluminescence signal as direct measures of cellular activity.
The integrity of the blood-brain barrier (BBB) can significantly influence the availability of luciferase substrates and thus affect the bioluminescence signal, potentially leading to misleading conclusions.
Combining BLI with other techniques, such as immunohistochemistry and ex vivo luciferase assays, is crucial for validating findings and distinguishing between changes in gene expression and changes in BBB permeability.